Research ArticleInflammation, Immunopharmacology, and Asthma
Unexpected Potency Differences between B-Cell–Activating Factor (BAFF) Antagonist Antibodies against Various Forms of BAFF: Trimer, 60-Mer, and Membrane-Bound
Amy M. Nicoletti, Cynthia Hess Kenny, Ashraf M. Khalil, Qi Pan, Kerry L. M. Ralph, Julie Ritchie, Sathyadevi Venkataramani, David H. Presky, Scott M. DeWire and Scott R. Brodeur
Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 37-44; DOI: https://doi.org/10.1124/jpet.116.236075
Amy M. Nicoletti
Immune Modulation and Biotherapeutics Discovery, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut
Cynthia Hess Kenny
Immune Modulation and Biotherapeutics Discovery, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut
Ashraf M. Khalil
Immune Modulation and Biotherapeutics Discovery, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut
Qi Pan
Immune Modulation and Biotherapeutics Discovery, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut
Kerry L. M. Ralph
Immune Modulation and Biotherapeutics Discovery, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut
Julie Ritchie
Immune Modulation and Biotherapeutics Discovery, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut
Sathyadevi Venkataramani
Immune Modulation and Biotherapeutics Discovery, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut
David H. Presky
Immune Modulation and Biotherapeutics Discovery, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut
Scott M. DeWire
Immune Modulation and Biotherapeutics Discovery, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut
Scott R. Brodeur
Immune Modulation and Biotherapeutics Discovery, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleInflammation, Immunopharmacology, and Asthma
BAFF Antibodies Differ in Inhibitory Potency against BAFF Forms
Amy M. Nicoletti, Cynthia Hess Kenny, Ashraf M. Khalil, Qi Pan, Kerry L. M. Ralph, Julie Ritchie, Sathyadevi Venkataramani, David H. Presky, Scott M. DeWire and Scott R. Brodeur
Journal of Pharmacology and Experimental Therapeutics October 1, 2016, 359 (1) 37-44; DOI: https://doi.org/10.1124/jpet.116.236075
Research ArticleInflammation, Immunopharmacology, and Asthma
BAFF Antibodies Differ in Inhibitory Potency against BAFF Forms
Amy M. Nicoletti, Cynthia Hess Kenny, Ashraf M. Khalil, Qi Pan, Kerry L. M. Ralph, Julie Ritchie, Sathyadevi Venkataramani, David H. Presky, Scott M. DeWire and Scott R. Brodeur
Journal of Pharmacology and Experimental Therapeutics October 1, 2016, 359 (1) 37-44; DOI: https://doi.org/10.1124/jpet.116.236075
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement